ADC Therapeutics SA ADCT:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EST
23.46UNCH (UNCH)
Volume
1,536
Close
23.46quote price arrow up+0.71 (+3.12%)
Volume
116,417
52 week range
21.51 - 56.59

...

Loading . . .

KEY STATS

  • Open23.18
  • Day High24.30
  • Day Low22.32
  • Prev Close22.75
  • 52 Week High56.59
  • 52 Week High Date07/02/20
  • 52 Week Low21.51
  • 52 Week Low Date03/05/21
  • Market Cap1.80B
  • Shares Out76.72M
  • 10 Day Average Volume0.24M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-3.05
  • P/E (TTM)-7.69
  • Fwd P/E (NTM)-10.46
  • EBITDA (MRQ)-112.745M
  • ROE (MRQ)-
  • Revenue (MRQ)2.86M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-3,892.33%
  • Debt To Equity (MRQ)10.66%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest ADC Therapeutics SA News

There is no recent news for this security.

Latest ADCT News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
ADC Therapeutics SA is a Switzerland-based clinical-stage oncology drug discovery and development company. It develops antibody drug conjugates (ADCs) for the treatment of both solid and hematological cancers. It employs monoclonal antibodies specific to particular tumor antigens conjugated to a class of pyrrolobenzodiazepine (PBD)-based warheads to selectively target and kill cancer cells. The Company has multiple PBD-based ADCs in ongoing clinical trials, ranging from first...
Ron Squarer
Chairman
Michael Forer
Vice Chairman
Chris Martin
Chief Executive Officer
Address
Biopole, route de la Corniche 3B
Epalinges
1066
Switzerland